DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Neurocrine Biosciences, Inc. (NBIX)
« Back to company indexNBIX Chatter Timeline
Stock Ticker for NBIX
Most Active Tweeters for NBIX
| User | Tweets |
|---|---|
| @AmericanBanking | 6 |
| @portefeuillefun | 6 |
| @HealthcareBeat | 5 |
| @Gambiste1 | 4 |
| @TheMarketsDaily | 3 |
Recent Tweets for NBIX
 |
@1MinuteStock Wondering about risks of $NBIX? The 21-day volatility is 22.45% https://t.co/iMoZl9zaLE April 9th 2020, 7:04pm |
 |
@Gambiste1 RT @ExecPayOrg: Neurocrine Biosciences CEO Kevin Gorman's 2019 pay rises 9% to $9.5M https://t.co/vrTdx0xnV1 $NBIX #execpay April 9th 2020, 4:04pm |
 |
@ExecPayOrg Neurocrine Biosciences CEO Kevin Gorman's 2019 pay rises 9% to $9.5M https://t.co/vrTdx0xnV1 $NBIX #execpay April 9th 2020, 4:04pm |
 |
@StockTexts $NBIX Neurocrine Biosciences, Inc. SEC Filing: Form DEF 14A https://t.co/6iV3lHauZw April 9th 2020, 4:04pm |
 |
@Stock_News_Now $NBIX: New SEC Filing for NBIX: Form 8-K (No. 0001564590-20-016098): https://t.co/mebj8nzPTK April 9th 2020, 4:04pm |
 |
@portefeuillefun Sold 0.5k $NBIX at $96.965, now 2k #vssporte shares. April 9th 2020, 2:04pm |
 |
@AmericanBanking Q2 2020 Earnings Estimate for Neurocrine Biosciences, Inc. Issued By Piper Sandler $NBIX https://t.co/j3oHieOZjY #stocks April 9th 2020, 10:04am |
 |
@dispatchtribune Q2 2020 Earnings Estimate for Neurocrine Biosciences, Inc. Issued By Piper Sandler $NBIX https://t.co/jrTOPVvl36 April 9th 2020, 10:04am |
 |
@dailypoliticaln Q2 2020 Earnings Estimate for Neurocrine Biosciences, Inc. Issued By Piper Sandler $NBIX https://t.co/oXd0hEq2G3 April 9th 2020, 10:04am |
 |
@stocknewstimes Piper Sandler Research Analysts Cut Earnings Estimates for Neurocrine Biosciences, Inc. $NBIX https://t.co/EFL44xUqsq April 9th 2020, 10:04am |
 |
@bbnsnews Zacks: Analysts Expect Neurocrine Biosciences, Inc. $NBIX Will Announce Quarterly Sales of $221.83 Million https://t.co/TWdzZTVeqb April 8th 2020, 3:04pm |
 |
@WeekHerald $0.57 EPS Expected for Neurocrine Biosciences, Inc. $NBIX This Quarter https://t.co/4LCZOzYKD0 April 8th 2020, 3:04pm |
 |
@ConsumerFeed Neurocrine Biosciences $NBIX Receives Buy Rating from Royal Bank of Canada https://t.co/DirYs6brwd April 8th 2020, 10:04am |
|
@ConsumerFeed Needham & Company LLC Reiterates Neutral Rating for Neurocrine Biosciences $NBIX https://t.co/QT5PudhmX0 April 8th 2020, 10:04am |
 |
@TheMarketsDaily Neurocrine Biosciences $NBIX Stock Rating Reaffirmed by Needham & Company LLC https://t.co/SelOIbWTWs April 8th 2020, 10:04am |
 |
@dakotafinancial Neurocrine Biosciences $NBIX Receives Buy Rating from Royal Bank of Canada https://t.co/13FZS84sbN April 8th 2020, 10:04am |
 |
@TranscriptDaily Needham & Company LLC Reiterates Neutral Rating for Neurocrine Biosciences $NBIX https://t.co/vR1f2MHAtb April 8th 2020, 10:04am |
|
@TranscriptDaily Neurocrine Biosciences $NBIX Receives Buy Rating from Royal Bank of Canada https://t.co/BpF6liJJKL April 8th 2020, 10:04am |
 |
@SwingTradeBot Fell Below 50 DMA today: $NBIX $UNG ... https://t.co/j2lcQPb078 April 8th 2020, 10:04am |
|
@dakotafinancial Neurocrine Biosciences $NBIX Given New Price Target at Piper Sandler https://t.co/grwYLWNaW9 April 8th 2020, 10:04am |
|
@ConsumerFeed Neurocrine Biosciences $NBIX Given New Price Target at Piper Sandler https://t.co/c24Q2YmjBi April 8th 2020, 10:04am |
|
@TheMarketsDaily Neurocrine Biosciences $NBIX Given New Price Target at Piper Sandler https://t.co/7qxSv9nweG April 8th 2020, 10:04am |
|
@TranscriptDaily Neurocrine Biosciences $NBIX Price Target Lowered to at Piper Sandler https://t.co/PsqqCFehdA April 8th 2020, 10:04am |
|
@AmericanBanking Neurocrine Biosciences $NBIX PT Lowered to https://t.co/Tz3WYspdiP #stocks April 8th 2020, 9:04am |
|
@AmericanBanking Neurocrine Biosciences $NBIX Rating Reiterated by Needham & Company LLC https://t.co/Zaw24fo5WL #stocks April 8th 2020, 8:04am |
|
@AmericanBanking Royal Bank of Canada Reiterates “Buy” Rating for Neurocrine Biosciences $NBIX https://t.co/hE1wCimM3A #stocks April 8th 2020, 8:04am |
 |
@ResearchPool $NBIX #Neurocrine Biosciences Inc. NEUROCRINE BSCS.INCO. sees an upgrade to Positive due to a better fundamental st… https://t.co/p4Vyi3th4t April 8th 2020, 3:04am |
 |
@gcassidy718 $NBIX this is the time you buy equities thank you fed 2.09 % change recently https://t.co/lgEOaT4j7X April 7th 2020, 3:04pm |
 |
@HealthcareBeat Neurocrine Biosciences Trading 6.3% Higher $NBIX https://t.co/3zrlWpWwXk April 7th 2020, 10:04am |
|
@dailypoliticaln Neurocrine Biosciences $NBIX Stock Price Up 6.3% https://t.co/Wc77BXiWI7 April 7th 2020, 10:04am |
|
@dispatchtribune Neurocrine Biosciences $NBIX Stock Price Up 6.3% https://t.co/qMDAmdA11k April 7th 2020, 10:04am |
|
@stocknewstimes Neurocrine Biosciences $NBIX Trading 6.3% Higher https://t.co/NZVOwlq0cO April 7th 2020, 10:04am |
|
@Gambiste1 RT @portefeuillefun: Bought 1k $NBIX at $87.99, now 2.5k #vssporte shares. April 6th 2020, 10:04am |
|
@Gambiste1 RT @portefeuillefun: Buy 1k $NBIX, limit $88.00, GTC. #vssporte April 6th 2020, 10:04am |
 |
@portefeuillefun Bought 1k $NBIX at $87.99, now 2.5k #vssporte shares. April 6th 2020, 9:04am |
|
@portefeuillefun Buy 1k $NBIX, limit $88.00, GTC. #vssporte April 6th 2020, 8:04am |
 |
@WatchlistN Brokerages Anticipate Neurocrine Biosciences, Inc. $NBIX Will Post Earnings of $0.57 Per Share https://t.co/0H83lc4LUm April 6th 2020, 7:04am |
 |
@ZolmaxNews Zacks: Brokerages Expect Neurocrine Biosciences, Inc. $NBIX Will Announce Earnings of $0.57 Per Share https://t.co/3Zq3uhgQbo April 6th 2020, 7:04am |
|
@AmericanBanking Neurocrine Biosciences, Inc. $NBIX Expected to Post Quarterly Sales of $221.83 Million https://t.co/mVxswHNn68 #stocks April 5th 2020, 6:04am |
|
@HealthcareBeat Nelson Van Denburg & Campbell Wealth Management Group Raises Stock Position in Neurocrine Biosciences $NBIX https://t.co/eHN1hlaF2q April 5th 2020, 4:04am |
 |
@Briefingcom $NBIX: Neurocrine Biosci provided an update regarding the company's business operations during the COVID-19... https://t.co/tdyp4dlSzN April 3rd 2020, 10:04am |
|
@HealthcareBeat Redpoint Investment Management Pty Ltd Acquires Shares of 2,046 Neurocrine Biosciences $NBIX https://t.co/mabGYV7y5V April 3rd 2020, 9:04am |
|
@Gambiste1 RT @BioStocks: $VYGR $NBIX temporarily pause screening of new patients in the RESTORE-1 clinical trial of VY-AADC (NBIb-1817) for Parkinson… April 3rd 2020, 9:04am |
 |
@MarketCurrents $NBIX - Neurocrine Bio updates business amid COVID-19 https://t.co/koSsotZRr9 April 3rd 2020, 8:04am |
 |
@otcdynamics $NBIX Neurocrine Biosciences Provides COVID-19 Business Update https://t.co/UwKymErBBH April 3rd 2020, 8:04am |
 |
@BioStocks $VYGR $NBIX temporarily pause screening of new patients in the RESTORE-1 clinical trial of VY-AADC (NBIb-1817) for… https://t.co/2BkswldcqZ April 3rd 2020, 8:04am |
 |
@VisualStockRSRC $NBIX - Neurocrine Biosciences Provides COVID-19 Business Update https://t.co/AWbf4UTFpB April 3rd 2020, 8:04am |
|
@dakotafinancial $0.57 Earnings Per Share Expected for Neurocrine Biosciences, Inc. $NBIX This Quarter https://t.co/lAMIrEHKhi April 3rd 2020, 8:04am |
|
@dailypoliticaln $0.57 Earnings Per Share Expected for Neurocrine Biosciences, Inc. $NBIX This Quarter https://t.co/yOEW8oMW2Z April 3rd 2020, 8:04am |
|
@AmericanBanking $0.57 Earnings Per Share Expected for Neurocrine Biosciences, Inc. $NBIX This Quarter https://t.co/Z21tadaZvs #stocks April 3rd 2020, 8:04am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2020. All rights reserved.